Autologous Stem Cell Transplantation (ASCT) for the Treatment of Patients with Waldenstrom’s Macroglobulinemia / Lymphoplasmacytic Lymphoma (WM/LPL). a Risk Factor Analysis By the European Society for Blood and Marrow Transplantation (EBMT) Lymphoma Working Party
暂无分享,去创建一个
S. Montoto | P. Mazza | G. Mufti | P. Chevallier | D. Niederwieser | P. Dreger | C. Kyriakou | J. Cornelissen | C. Thieblemont | J. Vernant | P. Zachée | A. Sureda | H. Finel | A. Boumendil | R. Hamladji